Germany
Japan
United Kingdom
China
Rabbit monoclonal anti-CHK1 antibody for SISCAPA, clone OTIR3G7
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Antibodies
View as table Download
Rabbit monoclonal anti-ERK3 antibody for SISCAPA, clone OTIR5F3
| Applications | SISCAPA |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Rabbit polyclonal Bi-Phospho-ERK1/2(T202/Y204) Antibody
| Applications | Dot, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This ERK1/2 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding T202/Y204 of human ERK1/2. |
| Modifications | Phospho-specific |
Rabbit anti-VEGFR (Phospho-Tyr951) polyclonal antibody (Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from humanVEGFR2 around the phosphorylation site of tyrosine 951 (K-D-YP-V-G). |
| Modifications | Phospho-specific |
Goat Polyclonal Anti-VEGFR2 Antibody
| Applications | WB |
| Reactivities | Canine, Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Purified recombinant peptide derived from the N-terminus (residues 20-125 aa) of human VEGFR2 produced in E. coli. |
Rabbit polyclonal RIPK2 (Ser176) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human RIPK2 around the phosphorylation site of serine 176 (S-L-SP-Q-S). |
| Modifications | Phospho-specific |
Rabbit Polyclonal ZIPK Antibody
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | ZIP kinase antibody was raised against a peptide corresponding to amino acids near the center of human ZIP kinase. The immunogen is located within amino acids 270 - 320 of ZIPK. |
Rabbit Polyclonal antibody to CaMKII delta (calcium/calmodulin-dependent protein kinase II delta)
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment contain a sequence corresponding to a region within amino acids 249 and 445 of CaMK2D (Uniprot ID#Q13557) |
Rabbit polyclonal TGFBR2 (Ab-250) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human TGFBR2 around the phosphorylation site of serine 250 (D-R-SP-D-I). |
Rabbit Polyclonal antibody to Activin A Receptor type IIA (activin A receptor, type IIA)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fragment corresponding to a region within amino acids 267 and 513 of Activin A Receptor type IIA (Uniprot ID#P27037) |
Rabbit polyclonal CaMKII (Thr305) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human CaMKII around the phosphorylation site of threonine 305 (I-L-TP-T-M). |
| Modifications | Phospho-specific |
Rabbit polyclonal anti-CLK2 antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human CLK2. |
Rabbit polyclonal CDK5 (Ab-15) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human CDK5 around the phosphorylation site of tyrosine 15 (G-T-YP-G-T) |
Rabbit polyclonal MAP2K7 (Ser271) antibody(Phospho-specific)
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human MAP2K7 around the phosphorylation site of serine 271 (V-D-SP-K-A). |
| Modifications | Phospho-specific |
Rabbit Polyclonal ASK1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | ASK1 antibody was raised against a 16 amino acid peptide from near the amino terminus of human ASK1. |
Rabbit polyclonal ETK / BMX(Ab-566) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human ETK around the phosphorylation site of tyrosine 566 (D-Q-YP-V-S). |
Rabbit polyclonal anti-PLK3 antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized peptide derived from internal of human PLK3. |
Rabbit polyclonal JAK2 (Tyr570) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human JAK2 around the phosphorylation site of tyrosine 750 (G-D-YP-G-Q). |
| Modifications | Phospho-specific |
Rabbit Polyclonal LIMK1/2 (Thr508/505) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human LIMK1/2 around the phosphorylation site of Threonine 508/505 |
| Modifications | Phospho-specific |
Rabbit Polyclonal Trk B (Tyr515) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human Trk B around the phosphorylation site of Tyrosine 515 (peptide seq 509-521aa: VIENPQY(p)FGITN) |
| Modifications | Phospho-specific |
Rabbit Polyclonal ROCK1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human ROCK1 |
Rabbit polyclonal CSFR (Ab-809) antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human CSFR around the phosphorylation site of tyrosine 809 (S-N-YP-I-V). |
Active filters
Isotypes
- IgG
Families
- Protein Kinase
Availabilities
- In Stock
Filter by
Category
Target Symbol
- EGFR (26)
- AKT1 (18)
- CHEK1 (13)
- BRAF (11)
- PDGFRB (11)
- PRKCD (11)
- MET (10)
- PAK1 (10)
- SRC (10)
- ERBB2 (9)
- FGFR1 (9)
- MAP2K4 (9)
- MAPK14 (9)
- RAF1 (9)
- RPS6KB1 (9)
- CHUK (8)
- CSF1R (8)
- GSK3A (8)
- IGF1R (8)
- JAK2 (8)
- MAP2K1 (8)
- MTOR (8)
- PRKCA (8)
- PTK2 (8)
- SYK (8)
- ABL1 (7)
- CDK2 (7)
- EPHA2 (7)
- MAPK3 (7)
- RPS6KA5 (7)
- CAMK2A (6)
- ERBB3 (6)
- IKBKB (6)
- INSR (6)
- KDR (6)
- MAPK8 (6)
- PAK2 (6)
- PRKD1 (6)
- BMX (5)
- CAMK2B (5)
- CDK1 (5)
- CHEK2 (5)
- LIMK1 (5)
- MAP2K6 (5)
- MAP3K7 (5)
- PAK5 (5)
- PRKAA1 (5)
- STK11 (5)
- STK39 (5)
- AKT2 (4)
- ALK (4)
- BCR (4)
- CDK5 (4)
- EIF2AK3 (4)
- EPHA3 (4)
- FGFR2 (4)
- FYN (4)
- KIT (4)
- LIMK2 (4)
- MAP2K3 (4)
- MAP3K5 (4)
- NTRK1 (4)
- NTRK2 (4)
- PRKCQ (4)
- PRKCZ (4)
- RPS6KA1 (4)
- RPS6KB2 (4)
- TNK2 (4)
- WNK1 (4)
- AATK (3)
- ACVR1C (3)
- ADCK1 (3)
- BMPR2 (3)
- CDK10 (3)
- COQ8B (3)
- CSNK1A1 (3)
- EPHB1 (3)
- EPHB6 (3)
- FES (3)
- FGFR3 (3)
- JAK1 (3)
- LATS1 (3)
- LCK (3)
- LYN (3)
- MAP2K2 (3)
- MAP3K4 (3)
- MAP3K8 (3)
- MAP4K1 (3)
- MAPK1 (3)
- MAPK6 (3)
- MAPKAPK2 (3)
- MERTK (3)
- MKNK1 (3)
- PDK4 (3)
- PDPK1 (3)
- PRKACG (3)
- PRKCB (3)
- PRKCG (3)
- ROCK1 (3)
- ROCK2 (3)
Reactivities
Applications
Antibody Hosts
Clonalities
Conjugates
Modifications
Pathways
- MAPK signaling pathway (291)
- Pathways in cancer (258)
- ErbB signaling pathway (226)
- Focal adhesion (218)
- Neurotrophin signaling pathway (170)
- Prostate cancer (168)
- Chemokine signaling pathway (161)
- GnRH signaling pathway (159)
- Glioma (149)
- Regulation of actin cytoskeleton (147)
- Colorectal cancer (139)
- Insulin signaling pathway (138)
- Fc epsilon RI signaling pathway (135)
- Pancreatic cancer (134)
- Melanoma (133)
- T cell receptor signaling pathway (128)
- Progesterone-mediated oocyte maturation (127)
- Fc gamma R-mediated phagocytosis (122)
- Non-small cell lung cancer (119)
- Endocytosis (117)
- Gap junction (112)
- Adherens junction (110)
- Axon guidance (110)
- Toll-like receptor signaling pathway (110)
- Acute myeloid leukemia (109)
- VEGF signaling pathway (108)
- Endometrial cancer (107)
- Epithelial cell signaling in Helicobacter pylori infection (106)
- Chronic myeloid leukemia (101)
- Calcium signaling pathway (100)
- Renal cell carcinoma (98)
- Bladder cancer (90)
- Vascular smooth muscle contraction (90)
- mTOR signaling pathway (90)
- Long-term potentiation (87)
- Cytokine-cytokine receptor interaction (86)
- B cell receptor signaling pathway (84)
- Natural killer cell mediated cytotoxicity (84)
- Adipocytokine signaling pathway (79)
- Oocyte meiosis (77)
- Tight junction (73)
- Melanogenesis (70)
- Long-term depression (69)
- Wnt signaling pathway (65)
- Type II diabetes mellitus (56)
- Apoptosis (54)
- Small cell lung cancer (54)
- Cell cycle (53)
- NOD-like receptor signaling pathway (52)
- TGF-beta signaling pathway (46)
- Dorso-ventral axis formation (44)
- Leukocyte transendothelial migration (43)
- RIG-I-like receptor signaling pathway (43)
- Thyroid cancer (38)
- Jak-STAT signaling pathway (36)
- Prion diseases (33)
- p53 signaling pathway (32)
- Amyotrophic lateral sclerosis (ALS) (25)
- Pathogenic Escherichia coli infection (25)
- Olfactory transduction (24)
- Vibrio cholerae infection (22)
- Alzheimer's disease (19)
- Hedgehog signaling pathway (19)
- Cytosolic DNA-sensing pathway (15)
- Hematopoietic cell lineage (14)
- Phosphatidylinositol signaling system (14)
- Viral myocarditis (12)
- Regulation of autophagy (9)
- Dilated cardiomyopathy (8)
- Taste transduction (8)
- Hypertrophic cardiomyopathy (HCM) (7)
- PPAR signaling pathway (5)
- Primary immunodeficiency (5)
- Basal cell carcinoma (3)
- Circadian rhythm - mammal (3)
- Basal transcription factors (2)
- Non-homologous end-joining (2)
- Parkinson's disease (2)
- Ubiquitin mediated proteolysis (2)
- Purine metabolism (1)